Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Ultrahigh Resolution of 3D Human Brain Offered Free for Researchers

By BiotechDaily International staff writers
Posted on 03 Jul 2013
Image: The three-dimensional virtual brain is based on data from more than 7,400 tissue sections, each of them only 20 micrometers-thick, which were obtained from a human brain (Photo courtesy of werbefoto-burger.ch/Fotolia)
Image: The three-dimensional virtual brain is based on data from more than 7,400 tissue sections, each of them only 20 micrometers-thick, which were obtained from a human brain (Photo courtesy of werbefoto-burger.ch/Fotolia)
A milestone three-dimensional (3D) digital reconstruction of a complete human brain, called the BigBrain, for the first time reveals the brain anatomy in microscopic clarity at a spatial resolution of 20 micrometers, exceeding that of existing reference brains presently in the public domain.

The new application is made freely available to the broader scientific community to facilitate the exploration of the field of neuroscience. Researchers from Germany and Canada, who collaborated on the ultra-high resolution brain model, presented their project in the June 21, 2013, issue of the journal Science. “The authors pushed the limits of current technology,” said Science’s senior editor Peter Stern about the international scientific effort. “Such spatial resolution exceeds that of presently available reference brains by a factor of 50 in each of the three spatial dimensions.”

The sophisticated modern image processing technology reveal a never before seen look at the very fine specifics of the human brain’s microstructure (cellular level). The anatomic tool will allow for 3D cytoarchitectonic mapping of the human brain and act as an atlas for small cellular circuit data (single layers or sublayers of the cerebral cortex), explained the researchers.

Until recently, reference brains did not probe further than the macroscopic, or visible, components of the brain. Now, the BigBrain provides a resolution much finer than the typical 1 mm resolution from MRI studies.

The project “has been a tour-de-force to assemble images of over 7,400 individual histological sections, each with its own distortions, rips, and tears, into a coherent 3D volume,” said senior author Dr. Alan Evans, a professor at the Montreal Neurological Institute at McGill University (Montreal, QC, Canada). “This dataset allows for the first time a 3D exploration of human cytoarchitectural anatomy.”

Thin sections of a 65-year-old human female brain, which was embedded in paraffin wax, were cut with a special large-scale tool called a microtome. Then, the 20-micrometer-thick histologic sections were mounted on slides, stained to detect cell structures, and finally digitized with a high-resolution flatbed scanner so researchers could reconstruct the high-resolution 3D brain model. It took approximately 1,000 hours to gather the data. The final images revealed discrepancies in the laminar pattern between brain areas.
The new reference brain, which is part of the European Human Brain Project, serves as a powerful tool to advance neuroscience research and “redefines traditional maps from the beginning of the 20th century,” explained lead author Dr. Katrin Amunts from the Research Center Jülich and director of the Cecile and Oskar Vogt Institute for Brain Research at the Heinrich Heine University Düsseldorf (Germany). “The famous cytoarchitectural atlases of the early 1900s were simplified drawings of a brain and were based on pure visual analysis of cellular organization patterns,” added Dr. Amunts.

Because of the ernormous volume of this dataset, the researchers noted that there will be a drive by those who want to use it to develop new and helpful applications for visualization, data management, and analysis. “We plan to repeat this process in a sample of brains so that we can quantify cytoarchitectural variability,” said Dr. Evans. “We will also integrate this dataset with high-resolution maps of white matter connectivity in postmortem brains. This will allow us to explore the relationship between cortical microanatomy and fiber connectivity,” said Dr. Amunts.

“We are planning to integrate our receptor data of the human brain in the reference frame provided by the BigBrain,” continued senior coauthor Dr. Karl Zilles, who is senior professor of the Jülich Aachen Research Alliance and former director of the Cecile and Oskar Vogt Institute for Brain Research at the Heinrich Heine University Düsseldorf (Germany). “We will also transfer high-resolution maps of quantitative data on the regional and laminar distribution of native receptor complexes to the BigBrain. This will allow us to explore the relationship between cortical microanatomy and key molecules of neurotransmission.”

The extremely detailed anatomic resolution will allow scientists to gather clues into the neurobiologic foundation of cognition, language, emotions, and other processes, according to the study. The researchers in addition plan to extract measurements of cortical thickness to gain insights into better understanding aging and neurodegenerative disorders; create cortical thickness maps to compare data from in vivo imaging; incorporate gene expression data from the Allen Institute for Brain Science (Seattle, WA, USA); and generate a brain model with a resolution of 1 micrometer to capture details of single cell morphology.

Public access of the BigBrain dataset will be provided through the McGill’s CBRAIN Portal, with free registration, according to the researchers.

Related Links:

Montreal Neurological Institute at McGill University
Heinrich Heine University Düsseldorf
CBRAIN Portal



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The European Commission has approved the use of Avastin combined with chemotherapy as a treatment for women with recurrent ovarian cancer (Photo courtesy of Genentech).

Drug for Treatment of Platinum Resistant Recurrent Ovarian Cancer Approved for Use in Europe

For the first time in more than 15 years the European Commission (EC) has approved a new therapeutic option for the most difficult to treat form of ovarian cancer. Ovarian cancer causes more deaths... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Business

view channel

Global Computational Biology Sector Expected to Reach over USD 4 Billion by 2020

The global market for computational biology is expected to reach USD 4.285 billion by 2020 growing at a compound annual growth rate (CAGR) of 21.1%, according to new market research. Steady surge in the usage and application of computational biology for bioinformatics R&D programs designed for sequencing genomes... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.